Wellmedr vs Maximus: pricing, prescriptions, and program differences
Wellmedr vs Maximus answers: both offer compounded GLP-1 weight loss care online, but Wellmedr highlights lower advertised starting prices and lifetime locked-in pricing while Maximus emphasizes a flat $132.99/month semaglutide plan with telemedicine and prescriptions through trusted U.S. pharmacies. Early verdict: choose Wellmedr if you prioritize advertised lower starting rates and lifetime price protections; choose Maximus if you want a straightforward flat-rate semaglutide plan approved by licensed doctors and available in most states.
See Wellmedr plans and starting prices
How Wellmedr and Maximus differ at a glance
Both providers offer compounded GLP-1 medications supplied via U.S. pharmacies. The most distinctive differences supported by the source are: starting price and pricing model; claims and guarantees; clinician approval and telemedicine flow; state availability and program scale; and which medications or branded products are highlighted.
Starting price and pricing model
Wellmedr advertises GLP-1 plans starting at $89 per month and promotes lifetime locked-in pricing plus no dose-based price increases. Maximus lists a flat low rate of $132.99 per month for semaglutide and positions that as a low flat rate. Both mention compounded medication sourcing from U.S. pharmacies, but Wellmedr emphasizes promotional offers like Labor Day Sale details captured on its landing page.
Guarantees, promotions, and claims
Wellmedr includes explicit promotional claims in the captured evidence: lifetime locked-in pricing, a new customer offer of $150 off for life, and a money back guarantee claiming a 100% refund if you do not lose weight in 90 days. Maximus does not show a weight-loss refund guarantee in the captured evidence but does state a refund of medication costs if you are not approved for treatment.
View Maximus semaglutide pricing and availability
Clinical review, telemedicine, and approvals
Maximus emphasizes prescriptions approved by licensed doctors and convenient telemedicine access with no clinic visits. Wellmedr also requires clinician review and medical evaluation; its landing-page evidence notes same-day review and that all treatment plans require medical evaluation and clinician approval. Maximus specifically notes eligibility in all 50 states except Mississippi for its Weight Loss Protocol, while Wellmedr’s evidence cautions readers to confirm eligibility, state availability, and clinician approval before enrollment.
Medications offered and regulatory note
Wellmedr lists multiple GLP-1 offerings in captured evidence including tirzepatide plans starting at $89 a month and semaglutide plans starting at $49 a month in some promoted offers, as well as branded mentions like Ozempic and Zepbound pricing shown on landing content. Wellmedr also states that it offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies and includes the regulatory notice that compounded medications are not evaluated by the FDA for safety or efficacy. Maximus likewise fills prescriptions through trusted U.S. pharmacies and notes its medication is compounded and not an FDA-approved finished product while using the same active ingredient as branded GLP-1 medications.
Direct comparison table
| Criteria | Wellmedr | Maximus |
|---|---|---|
| Starting price | Semaglutide from $89/mo (landing evidence) | $132.99 per month for semaglutide |
| Pricing model highlights | Lifetime locked-in pricing; no dose-based price increases; promotional offers | Low flat rate $132.99/mo; no membership fees |
| Clinician approval and telemedicine | Same-day review listed; clinician approval required | Prescriptions approved by licensed doctors; telemedicine, no clinic visit |
| State availability | Users should confirm state availability; eligibility may vary | Available in all 50 states except Mississippi |
| Guarantees and refunds | Money back guarantee claimed on landing page for 90 days | Medication costs refunded if not approved for treatment |
| Compounded medication note | Compounded GLP-1s from U.S. pharmacies; not evaluated by FDA | Compounded in U.S. pharmacies; not an FDA-approved finished product |
Shipping, dosing, and program details
Wellmedr’s captured evidence touts free overnight shipping and on-time refills guaranteed in landing content and mentions monthly shipping cadence for tirzepatide and semaglutide in some plans. Maximus lists free priority or expedited shipping and notes the option for custom titration in monthly or quarterly pricing unless a 90-day starter pack was purchased, and it highlights no in-person visits or insurance billing.
Check Wellmedr shipping and plan details
What is not supplied in the source
The captured evidence does not provide independent outcome verification beyond cited clinical research summaries, does not publish comprehensive public review counts for Wellmedr, and does not provide full details on long term renewal terms beyond the promotional claims. Do not assume additional guarantees or branded product availability beyond what each landing capture states.
Start Wellmedr enrollment and lock pricing
Final take: Wellmedr vs Maximus
In summary, Wellmedr positions itself around lower advertised starting prices, lifetime locked-in pricing and money back promotional claims captured on its landing evidence. Maximus positions a simple flat rate of $132.99 per month for semaglutide with licensed-doctor approvals, telemedicine access, and broad state availability except Mississippi. Both use U.S. pharmacies and both note that compounded medications are not FDA-reviewed as finished products.
Choose Wellmedr if you want advertised lower starting plans and lifetime price protections as presented in Wellmedr’s captured evidence. Choose Maximus if you prefer a straightforward, licensed-doctor telemedicine flow, a clear flat $132.99/month semaglutide price and wide state availability.